Matthias Aizenberg sits down with Ivan Kairatov, a biopharma expert whose work straddles gene editing and viral delivery, to unpack a new way of building better gene-editing vehicles by rethinking the cells that make them. Rather than only re-engineering virus-like particles, his team interrogated
Growing strain on MRI services collided with sharpening concerns over safety, supply, and sustainability, forcing radiology to rethink the chemistry behind contrast enhancement at scale, where about a third of scans depend on it for clarity that shapes life-changing decisions. That collision set
The strategic decision by Norfolk County councillors to authorize the sale of the Port Rowan Medical Centre represents a pivotal moment in the municipality's ongoing effort to divest itself from non-essential real estate holdings and focus on core service delivery. Located at 1035 Bay Street, this
The landscape of global pharmaceuticals is currently witnessing a profound architectural shift as legacy regulatory frameworks, once characterized by redundant clinical hurdles, give way to a streamlined, evidence-based approach designed to democratize access to biological therapies. For several
The recent breakthrough in oncological research has shifted the paradigm from analyzing what a tumor is composed of to understanding exactly how its internal components are physically positioned. Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have identified that the spatial
The abrupt cessation of nearly eight hundred million dollars in federal support has forced a paradigm shift in how the pharmaceutical industry approaches pandemic preparedness and biotechnological research. The landscape of global health security is currently witnessing a high-stakes test of
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48
